You are here

  • Home
  • Archive
  • Volume 27, Issue Suppl 1
  • 4CPS-187 Prognostic value of haematological inflammatory markers in patients with metastatic non-small cell lung cancer treated with pembrolizumab

Article metrics

Article menu

Download PDFPDF

Section 4: Clinical Pharmacy Services
4CPS-187 Prognostic value of haematological inflammatory markers in patients with metastatic non-small cell lung cancer treated with pembrolizumab
Free

 

Online download statistics by month:

Online download statistics by month: March 2020 to August 2024

AbstractFullPdf
Mar 2020603
Apr 20201805
May 2020403
Jun 20201404
Jul 2020801
Aug 2020002
Sep 20201004
Oct 2020606
Nov 2020200
Dec 2020401
Jan 2021402
Feb 2021409
Mar 2021800
Apr 2021001
May 2021208
Jun 2021103
Jul 2021004
Aug 2021103
Sep 2021004
Oct 20214016
Nov 20211409
Dec 20211201
Jan 2022902
Feb 2022400
Mar 20221801
Apr 2022807
May 20221008
Jun 2022502
Jul 20221500
Aug 20221204
Sep 20221006
Oct 2022808
Nov 20221003
Dec 2022401
Jan 2023201
Feb 2023601
Mar 2023602
Jul 2023403
Aug 2023201
Sep 2023002
Oct 2023802
Nov 2023802
Dec 20231300
Jan 2024601
Feb 2024401
Mar 20246014
Apr 20241608
May 2024400
Jun 2024400
Jul 2024002
Aug 2024803
Total3320174